Phathom Pharmaceuticals (PHAT) Invested Capital (2019 - 2021)

Phathom Pharmaceuticals (PHAT) has 3 years of Invested Capital data on file, last reported at $10.3 million in Q2 2021.

• On a quarterly basis, Invested Capital rose 644.78% year-over-year to $10.3 million in Q2 2021; TTM through Mar 2022 was $10.3 million, a 60.31% decrease from a year earlier, with the FY2020 full-year figure at $7.4 million, down 70.59% from the prior year.
• Invested Capital for Q2 2021 stood at $10.3 million, down from $11.8 million in the prior quarter.
• Over the last five years, Invested Capital for PHAT reached as high as $50.0 million in Q1 2020 and fell as low as $1.4 million in Q2 2020.
• Historically, Invested Capital has averaged $17.1 million across 3 years, with a median of $11.1 million in 2021.
• Across the five-year window, Invested Capital sank 77.78% in 2020 and surged 644.78% in 2021, its largest moves.
• Year by year, Invested Capital stood at $25.0 million in 2019, then plunged by 70.59% to $7.4 million in 2020, then soared by 40.69% to $10.3 million in 2021.
• Per Business Quant data, the three most recent Invested Capital figures were $10.3 million in Q2 2021, $11.8 million in Q1 2021, and $7.4 million in Q4 2020.